Edarbi
Edarbi contains the active ingredient Azilsartan medoxomil, a medication used primarily for the management of hypertension. By blocking the action of certain chemicals in the body that tighten blood vessels, it helps to relax and widen the vessels, improving blood flow and reducing blood pressure. This medication is available in tablet form and is typically prescribed for daily use. Regular intake of Edarbi can contribute to better cardiovascular health by maintaining optimal blood pressure levels. It is generally recommended for adults with high blood pressure, offering an effective way to prevent complications associated with hypertension. Edarbi is part of the class of drugs known as angiotensin II receptor blockers (ARBs).Active substance:
Azilsartan medoxomilPharmachologic effect:
Edarbi is an angiotensin II receptor blocker (ARB) that selectively inhibits the binding of angiotensin II to the AT1 receptor, leading to vasodilation and a reduction in blood pressure.Indications:
- Hypertension
Contraindications:
- Hypersensitivity to azilsartan medoxomil or any component of the formulation
- Severe hepatic impairment
- Pregnancy
- Biliary obstruction
Side effects:
In order of decreasing probability: Dizziness, Fatigue, Diarrhea, Nausea, Hyperkalemia, Hypotension, Increased blood creatinine
Dosing and Administration:
The recommended starting dose of Edarbi is 40 mg once daily. The dose may be increased to a maximum of 80 mg once daily if additional blood pressure reduction is required. Edarbi can be taken with or without food.
Storage:
Store at a temperature not exceeding 30°C (86°F).
Edarbi
in Cyrillic : Эдарби
SUBSTANCE
Azilsartan medoxomil
DOSAGE FORM
tablets
MANUFACTURER
In Stock
available pack options :
| 40mg x 28 tablets | $37.90 | |
| 80mg x 28 tablets | $63.00 |
